Screener
MeiraGTx Holdings plc
MGTXMeiraGTx is a vertically integrated, clinical-stage biotechnology company focused on developing genetic medicines for both inherited and common diseases.
Earnings
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$7.1M
EPS estimate-$0.46
Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
MeiraGTx is a vertically integrated, clinical-stage biotechnology company focused on developing genetic medicines for both inherited and common diseases. The company leverages a proprietary end-to-end manufacturing platform and a transformative synthetic riboswitch technology to enable precise, dose-responsive gene regulation via oral small molecules.
Competitive position
A vertically integrated player with internal commercial-scale manufacturing and a unique synthetic riboswitch platform for dose-responsive gene expression.
GeographiesUnited Kingdom, Ireland, United States
Customer segmentsPatients, Biopharmaceutical Companies
Business modelR&D, Manufacturing, Licensing
SuppliersRaw material suppliers, Laboratory equipment providers, Clinical trial sites
CustomersSpecialty pharmacies, Hospitals, Biopharmaceutical licensing partners
CountryUnited States of America
Listed2018
Employees402.0
CEOAlexandria Forbes
SectorHealthcare
IndustryBiotechnology
Websitemeiragtx.com
FilingsSEC EDGAR
FAQ
- What is MeiraGTx Holdings plc's market cap?
- MeiraGTx Holdings plc (MGTX) has a market capitalization of $1.4B and trades on NASDAQ.
- What is MeiraGTx Holdings plc's revenue and profitability?
- MeiraGTx Holdings plc generated $397.5M in trailing twelve-month revenue with net income of $25.1M, representing a net margin of -615.3%, with free cash flow of -$81.1M. These figures are based on the Q2 2026 filing.
- Who are MeiraGTx Holdings plc's competitors?
- MeiraGTx Holdings plc's key competitors include Regeneron Pharmaceuticals, Voyager Therapeutics, REGENXBIO Inc., and others. These companies compete in similar markets and product categories.
- Who does MeiraGTx Holdings plc partner with?
- MeiraGTx Holdings plc's notable partners include Johnson & Johnson.
- What subsidiaries does MeiraGTx Holdings plc have?
- MeiraGTx Holdings plc's subsidiaries include MeiraGTx UK.
- Where is MeiraGTx Holdings plc headquartered?
- MeiraGTx Holdings plc is headquartered in United States of America and employs approximately 402 people. It has been publicly traded since 2018.
